Cardlytics Valuation
Is CDLX undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CDLX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CDLX ($3.93) is trading above our estimate of fair value ($3.54)
Significantly Below Fair Value: CDLX is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CDLX?
Key metric: As CDLX is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is CDLX's PS Ratio? | |
|---|---|
| PS Ratio | 0.7x |
| Sales | US$293.47m |
| Market Cap | US$199.73m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.2x |
| Enterprise Value/EBITDA | -9.7x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does CDLX's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 2.1x | ||
EVC Entravision Communications | 0.2x | n/a | US$225.0m |
SUNH Xuhang Holdings | 4.7x | n/a | US$273.6m |
PERI Perion Network | 0.7x | -8.7% | US$408.5m |
CTV Innovid | 3x | 9.0% | US$453.1m |
CDLX Cardlytics | 0.7x | 2.2% | US$199.7m |
Price-To-Sales vs Peers: CDLX is good value based on its Price-To-Sales Ratio (0.7x) compared to the peer average (2.1x).
Price to Sales Ratio vs Industry
How does CDLX's PS Ratio compare vs other companies in the US Media Industry?
Price-To-Sales vs Industry: CDLX is good value based on its Price-To-Sales Ratio (0.7x) compared to the US Media industry average (0.9x).
Price to Sales Ratio vs Fair Ratio
What is CDLX's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.7x |
| Fair PS Ratio | 0.6x |
Price-To-Sales vs Fair Ratio: CDLX is expensive based on its Price-To-Sales Ratio (0.7x) compared to the estimated Fair Price-To-Sales Ratio (0.6x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$3.93 | US$4.40 +12.0% | 11.1% | US$5.00 | US$4.00 | n/a | 5 |
| Nov ’25 | US$4.18 | US$6.90 +65.1% | 80.7% | US$18.00 | US$3.50 | n/a | 5 |
| Oct ’25 | US$3.11 | US$7.63 +145.2% | 78.9% | US$18.00 | US$3.50 | n/a | 4 |
| Sep ’25 | US$3.91 | US$7.63 +95.0% | 78.9% | US$18.00 | US$3.50 | n/a | 4 |
| Aug ’25 | US$7.94 | US$13.40 +68.8% | 18.6% | US$18.00 | US$11.00 | n/a | 5 |
| Jul ’25 | US$8.08 | US$13.40 +65.8% | 18.6% | US$18.00 | US$11.00 | n/a | 5 |
| Jun ’25 | US$8.76 | US$14.00 +59.8% | 20.2% | US$18.00 | US$12.00 | n/a | 3 |
| May ’25 | US$12.99 | US$17.67 +36.0% | 2.7% | US$18.00 | US$17.00 | n/a | 3 |
| Apr ’25 | US$14.46 | US$17.00 +17.6% | 8.3% | US$18.00 | US$15.00 | n/a | 3 |
| Mar ’25 | US$8.39 | US$11.67 +39.1% | 10.7% | US$13.00 | US$10.00 | n/a | 3 |
| Feb ’25 | US$7.64 | US$11.67 +52.7% | 10.7% | US$13.00 | US$10.00 | n/a | 3 |
| Jan ’25 | US$9.21 | US$12.33 +33.9% | 3.8% | US$13.00 | US$12.00 | n/a | 3 |
| Dec ’24 | US$8.50 | US$12.33 +45.1% | 3.8% | US$13.00 | US$12.00 | n/a | 3 |
| Nov ’24 | US$12.12 | US$17.00 +40.3% | 11.8% | US$19.00 | US$15.00 | US$4.18 | 2 |
| Oct ’24 | US$16.50 | US$17.00 +3.0% | 11.8% | US$19.00 | US$15.00 | US$3.11 | 2 |
| Sep ’24 | US$17.22 | US$17.00 -1.3% | 11.8% | US$19.00 | US$15.00 | US$3.91 | 2 |
| Aug ’24 | US$11.27 | US$8.00 -29.0% | 20.4% | US$10.00 | US$6.00 | US$7.94 | 3 |
| Jul ’24 | US$6.32 | US$8.00 +26.6% | 20.4% | US$10.00 | US$6.00 | US$8.08 | 3 |
| Jun ’24 | US$5.27 | US$6.70 +27.1% | 32.6% | US$10.00 | US$3.50 | US$8.76 | 5 |
| May ’24 | US$8.26 | US$6.10 -26.2% | 24.5% | US$8.00 | US$3.50 | US$12.99 | 5 |
| Apr ’24 | US$3.40 | US$5.60 +64.9% | 29.0% | US$8.00 | US$3.00 | US$14.46 | 5 |
| Mar ’24 | US$5.32 | US$8.80 +65.4% | 36.2% | US$14.00 | US$6.00 | US$8.39 | 5 |
| Feb ’24 | US$7.90 | US$8.80 +11.4% | 36.2% | US$14.00 | US$6.00 | US$7.64 | 5 |
| Jan ’24 | US$5.78 | US$9.80 +69.6% | 26.9% | US$14.00 | US$7.00 | US$9.21 | 5 |
| Dec ’23 | US$4.44 | US$9.80 +120.7% | 26.9% | US$14.00 | US$7.00 | US$8.50 | 5 |
| Nov ’23 | US$9.68 | US$14.00 +44.6% | 21.2% | US$19.00 | US$10.00 | US$12.12 | 5 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Match Group
US$7.9b
Engages in the provision of dating products.
MTCH
US$31.53
7D
2.7%
1Y
-1.6%
Yelp
US$2.3b
Operates a platform that connects consumers with local businesses in the United States and internationally.
YELP
US$36.13
7D
0.5%
1Y
-20.3%
Thryv Holdings
US$620.4m
Provides digital marketing solutions and cloud-based tools to the small-to-medium sized businesses in the United States.
THRY
US$14.90
7D
8.5%
1Y
-19.4%